As of May 27, 2025, Avacta Group PLC (AVCT.L) reports a EV/EBITDA of -8.86.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Avacta Group PLC's EV/EBITDA to Peers
To better understand Avacta Group PLC's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Avacta Group PLC (AVCT.L) | -8.86 |
| Centessa Pharmaceuticals PLC (CNTA) | 1496.62 |
| Formycon AG (FYB.DE) | 48.77 |
| Genus PLC (GNS.L) | 32.01 |
| Bioventix PLC (BVXP.L) | 13.81 |
| Abcam PLC (ABC.L) | 12.55 |
Compared to its competitors, Avacta Group PLC's EV/EBITDA is among the lowest compared to peers, which may indicate undervaluation or market concerns about future performance.